Clinical significance of serum thyroid hormone level in patients with breast cancer

Ning Zhang,Hong Zheng,Xichun Hu
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.23.019
2018-01-01
Journal of Modern Oncology
Abstract:Objective:To analyze the serum thyroid hormone level in patients with breast cancer and its clinical significance. Methods:Forty patients with malignant breast tumor,46 patients with benign breast tumor and 46 healthy people (control group)were enrolled in this study. Detect serum total triiodothyronine (T3),free triiodothyronine (FT3),total thyroid hormone (T4),free thyroxine (FT4),thyrotropin (TSH)and thyroid peroxidase (TPO-Ab) and relationship with clinicopathological factors of breast cancer. Results:The level of T3 in malignant breast tumor group was significantly lower than that in control group and benign breast tumor group (P<0. 05),and was related to tumor size and clinical stage (P<0. 05). The positive rate of TPO-Ab in malignant breast tumor group was signifi-cantly higher than benign breast tumor group and the control group (P<0. 05),and related with tumor size,TNM stage,ER expression,PR expression (P<0. 05). Conclusion:Serum thyroid hormone level in patients with breast cancer is related to the severity of the patient's condition,which helps to evaluate the condition and prognosis.
What problem does this paper attempt to address?